Special Drug Use Surveillance of Rozlytrek Capsule in Pediatric Patients - Advanced or recurrent solid tumors with NTRK gene fusions
Not Applicable
Recruiting
- Conditions
- Advanced or recurrent solid tumors with NTRK gene fusions
- Registration Number
- JPRN-UMIN000039670
- Lead Sponsor
- Chugai Pharmaceutical Co. Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method